Page last updated: 2024-10-27

flunitrazepam and Long QT Syndrome

flunitrazepam has been researched along with Long QT Syndrome in 2 studies

Flunitrazepam: A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug.
flunitrazepam : A 1,4-benzodiazepinone that is nitrazepam substituted by a methyl group at position 1 and by a fluoro group at position 2'. It is a potent hypnotic, sedative, and amnestic drug used to treat chronic insomnia.

Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ahn, HJ1
Jeong, WJ1
Kim, KJ1
Kim, SC1
Kim, DW1
Chang, HJ1
Kang, CS1
Oh, SK1
Cho, SU1
Min, JH1
Cho, YC1
Park, JS1
Ryu, S1
You, YH1
Lee, JW1
Kim, MS1
Hatta, K1
Takahashi, T1
Nakamura, H1
Yamashiro, H1
Asukai, N1
Matsuzaki, I1
Yonezawa, Y1

Other Studies

2 other studies available for flunitrazepam and Long QT Syndrome

ArticleYear
Serial plasma and urine measurements of a patient with acute intoxication of zolpidem and flunitrazepam resulting in QT prolongation and ventricular tachycardia.
    Clinical toxicology (Philadelphia, Pa.), 2020, Volume: 58, Issue:6

    Topics: Aged; Electrocardiography; Female; Flunitrazepam; Humans; Long QT Syndrome; Poisoning; Tachycardia,

2020
The association between intravenous haloperidol and prolonged QT interval.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Cohort Studies; Confidence Intervals; Cross-Sectio

2001